Cargando…
Novel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers
Gastrointestinal (GI) cancers, such as of the colon and pancreas, are highly resistant to both standard and targeted therapeutics. Therapy-resistant and heterogeneous GI cancers harbor highly complex signaling networks (the resistome) that resist apoptotic programming. Commonly used gemcitabine or p...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588517/ https://www.ncbi.nlm.nih.gov/pubmed/26228733 http://dx.doi.org/10.1159/000435814 |